COST-EFFECTIVENESS OF RIOCIGUAT FOR TREATMENT OF PATIENTS WITH INOPERABLE OR POST-OPERATIVE RECURRENT/PERSISTENT CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN TURKEY - (:unkn) unknown (ELSEVIER SCIENCE INC, 2015)